Episode 270: ESMO 2023: Belzutifan in Renal Cancer

Lisa Pickering, PhD, FRCP discusses 3 different renal cancer abstracts that were presented at ESMO 2023, including phase 3 data on belzutifan versus everolimus.

Dr. Pickering is a medical oncologist at The Royal Marsden Hospital in London, England.